Biomarkers For Identifying Neurodegenerative Disorders Early and Reliably - Primary Care (BioFINDER Primary Care)
The BioFINDER Primary Care Study follows individuals aged 40 years or older experiencing cognitive symptoms in Sweden. At recruitment, the participants were either seeking medical care due to mild cognitive symptoms in primary care units or were suspected to have a progressive neurodegenerative disorder including but not limited to Alzheimer's disease, Lewy body disease, frontotemporal lobar degeneration or subcortical vascular cognitive impairment. All patients classified as having subjective cognitive decline or mild cognitive impairment are followed longitudinally with annual visits including cognitive testing and clinical evaluation by a dementia expert. After the baseline assessments, a subsample of participants is enrolled in BioFINDER-2, undergoing BioFINDER-2 baseline assessments and longitudinal follow-ups.
Study design
Cohort
Number of participants at first data collection
1,200 (participants)
Recruitment is ongoing
Age at first data collection
≥ 40 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2020
Primary Institutions
Lund University (Lunds Universitet)
Skåne University Hospital (Skånes universitetssjukhus, SUS)
Profile paper DOI
Not available
Funders
Lund University (Lunds Universitet)
Ongoing?
Yes
Data types collected
- Audio or visual recordings (e.g. of child behaviour, facial expressions)
- Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Wearable devices
- None
- Magnetic Resonance Imaging (MRI)
- Positron Emission Tomography (PET)
- None
Engagement
Keywords
Consortia and dataset groups
